If CTIX had not acquired Polymedix, would it be worth only $1 ? Certainly not! Therefore, even if the B trial is not a great success there is absolutely no reason why the SP should plunge to one dollar. A correction of the SP would only be an irrational over reaction of the market. Considering the current CTIX pipeline, CTIX is clearly undervalued by the market at this time.